“eGenesis, a developer of human-compatible organs that are derived from pigs, raised $191 million in new venture capital funding.

Why it matters: There are over 100,000 people in the U.S. on organ transplant waiting lists, the vast majority of whom are in need of kidneys.

Catch up quick: eGenesis provided the genetically-edited porcine kidney used earlier this year in a landmark human transplant, and is working with the FDA to move into Phase 1 clinical trials.”

From Axios.